Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Pediatr Neurol. 2020 Jan 11;108:5–12. doi: 10.1016/j.pediatrneurol.2019.12.009

Table 2:

Antithrombotic treatment and stroke rates in blunt cerebrovascular injury (BCVI)

Cohort # total
trauma
patients
# patients
with
vascular
injury
Antithrombotic
treatment
Antithrombotic
w stroke
Not on
antithrombotic w
stroke
Azarakhsh 201313 5826 19 5 aspirin
2 low molecular weight heparin
0/7 (0%) 2/12 (17%)
Cook 201810 7440 96 57 aspirin
5 anticoagulation
6/57 on aspirin (11%) 3/34 (9%)
Jones 201212 14991 45 44 heparin (aspirin or anticlopidigrel may be substituted at attending discretion, exact number not specified) 1/44 (2%) 1/1 (100%)
Kopelman 201111 1209 11 2 aspirin 0/2 (0%) 3/9 (30%)